LENZ Therapeutics and JIXING Announce an Exclusive Greater China[...]
LENZ Therapeutics Announces Positive Topline Data from Phase 2 INSIGHT[...]
LENZ Therapeutics Announces $83.5 Million Series B Financing to Advance[...]
07/04/2024 | Press release | Distributed by Public on 07/04/2024 05:21
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact